Sweet-like syndrome induced by bortezomib

J Dtsch Dermatol Ges. 2013 Dec;11(12):1200-2. doi: 10.1111/ddg.12172. Epub 2013 Jul 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged, 80 and over
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Boronic Acids / adverse effects*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology*
  • Drug Eruptions / prevention & control
  • Humans
  • Male
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Pyrazines / adverse effects*
  • Pyrazines / therapeutic use
  • Sweet Syndrome / chemically induced*
  • Sweet Syndrome / pathology*
  • Sweet Syndrome / prevention & control
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib